Article information
Resumen
Presentamos un caso de desprendimiento placentario a las 20 semanas y 4 días de gestación, asociado a una coagulopatía de consumo con pruebas de coagulación que hacían pensar en una fibrinólisis primaria más que en la coagulación intravascular diseminada clásicamente descrita. Una revisión de la bibliografía nos aporta 6 casos de coagulopatía durante el segundo trimestre, de los cuales solamente tres fueron debidos a una fibrinólisis primaria. Apuntamos las posibilidades terapéuticas de esta coagulopatía.
Summary
We present a case of placental abruption at 20 weeks and 4 days of pregnancy associated to a consumptive coagulopathy with coagulation tests which suggested primary fibrynolysis rather than a classically described disseminated intravascular coagulation. A literature review revealed 6 cases of coagulopathy in the second trimester of which only 3 were due to a primary fibrinolysis. Management of this coagulopathy is discussed.
Full text is only aviable in PDF
Bibliografía
[1.]
RO Navmann, L. Weinstein.
Disseminated intravascular coagulation. The clinician’s dilemma.
Obstet Gynecol Surv, 40 (1987), pp. 487-492
[2.]
AL Bond, TG Edersheim, L Curry, ML Druzin, JM. Huston.
Expectant management of abruptio placentae before 35 weeks gestation.
Am J Perinatol, 6 (1989), pp. 121-123
[3.]
LL Cabero, J. Bellart.
Hemorragias del tercer trimestre.
Riesgo elevado obstétrico, pp. 109-130
[4.]
Alegre J Monleón, Sancho J Monleón, Rodríguez Domínguez, Marín A Perales, San J. Mínguez.
Asistencia al desprendimiento prematuro de la placenta normalmente inserta.
Manual de asistencia a la patología obstétrica, pp. 831-862
[5.]
LC Tejerizo, Moro F Corredera, Déiros A Teijelo, Ahedo L Cardeñoso, Escanilla JA. Pérez.
Asistencia al embarazo y parto con placenta previa.
Manual de asistencia a la patología obstétrica, pp. 863-878
[6.]
RD. Eden.
Alteraciones de los factores de la coagulopatía sanguínea.
Medicina clínica en obstetricia, pp. 1366-1374
[7.]
TP. Duffy.
Aspectos hematológicos del embarazo.
Complicaciones médicas del embarazo, pp. 62-82
[8.]
RI. Handin.
Trastornos de la coagulación y trombosis.
Harrison. Principios de medicina interna. I, 14, pp. 842-850
[9.]
AA Monteiro, AC Inocencio, CS. Jorge.
«Placental abruption » with disseminated intravascular coagulation in the second trimester of pregnancy with fetal survival.
Br J Obstet Gynaecol, 94 (1987), pp. 811-812
[10.]
Mechem C Crawford, RK Knopp, D. Feldman.
Painless abruptio placentae associated with disseminated intravascular coagulation and syncope.
Ann Emerg Med, 21 (1992), pp. 883-885
[11.]
F Debiève, M Gibon, K Thomas, T. Hubinont.
Coagulopathie de conssomation durant la grossesse: un cas d’afibrinogénémie du deuxième trimestre.
J Gynecol Obstet Biol Reprod, 24 (1995), pp. 860-862
[12.]
DR. Knab.
Abruptio placentae: An assessment of time and method of delivery.
Obstet Gynecol, 52 (1978), pp. 625-629
[13.]
M Käregärd, G. Gennser.
Incidence and recurrence rate of abruptio placentae in Sweden.
Obstet Gynecol, 67 (1986), pp. 523-528
[14.]
TN Abdella, BM Sibai, JM Jr Hays, BD. Anderson.
Relationship of hypertensive disease to abruptio placentae.
Obstet Gynecol, 63 (1984), pp. 365
[15.]
WW Hurd, M Miodovnik, V Hertzberg, JP. Lavin.
Selective management of abruptio placentae: A prospective study.
Obstet Gynecol, 61 (1983), pp. 467-773
[16.]
AF Saftlas, DR Olson, HK Atrash, R Rochar, D. Rowley.
National trends in the incidence of abruptio placentae, 1979-1987.
Obstet Gynecol, 78 (1991), pp. 1081-1086
[17.]
FG Cunningham, PC MacDonald, NF Gant, KJ Leveno, LC III Gilstrap, GDV Hankins, et al.
Hemorragia obstétrica.
Williams obstetrician, 20, pp. 693-727
[18.]
JA Pritchard, AL. Brekken.
Clinical and laboratory studies on severe abruptio placentae.
Am J Obstet Gynecol, 97 (1967), pp. 681-686
[19.]
JA Pritchard, FG Cunningham, SA Pritchard, RA. Mason.
On reducing the frecuency of severe abruptio placentae.
Am J Obstet Gynecol, 165 (1991), pp. 1345-1351
[20.]
JA Pritchard, RA Mason, M Corley, SA. Pritchard.
Genesis of severe placental abruption.
Am J Obstet Gynecol, 108 (1970), pp. 22-27
[21.]
JR. Green.
Placenta previa and abruptio placentae.
Maternal fetal medicine principles and practices, pp. 602-619
[22.]
KS Olah, HY Gee, PG. Needham.
The management of severe disseminated intravascular coagulopathy complicating placental abruption in the second trimester of pregnancy.
Br J Obstet Gynaecol, 95 (1988), pp. 419-420
[23.]
DPJ Barton, MJ Turner, JM. Strong.
Fetal survival following coagulopathy at 17 weeks gestation.
Obstet Gynecol, 74 (1989), pp. 468-469
[24.]
E Anteby, A Milwidsky, R Goshen, O. Shalev.
Primary fibrinogenolysis complicating second trimester placental separation.
Arch Gynecol Obstet, 251 (1992), pp. 51-53
[25.]
CL. Schneider.
The active principle of placental toxin: Thromboplastin, its inactivator in blood, antithromboplastin.
Am J Physiol, 149 (1947), pp. 123-129
[26.]
WH Seegers, CL. Schneider.
The nature of the blood coagulation mechanism and its relationship to some unsolved problems in obstetrics and gynecology. Fourth International and American Congress on Obstet and Gynecology.
pp. 469-472
[27.]
G Sher, BE. Statland.
Abruptio placentae with coagulopathy: a rational basis for management.
Clin Obst Gynecol, 28 (1985), pp. 15-23
[28.]
PDM Brandjes, BE Schenk, HR Büller, JW. Fencate.
Management of disseminated intravascular coagulation in obstetrics.
Eur J Obstet Gynecol Reprod Biol, 42 (1991), pp. 587-589
[29.]
A Estellés, J Aznar, J. Gilabert.
Diagnóstico analítico diferencial entre coagulación intravascular diseminada e hiperfibrinólisis.
Alteraciones de la hemostasia en obstetricia. Clínica Ginecológica, pp. 111-122
[30.]
J Gilabert, E Jolis, J Peiró, A Estellés, J. Aznar.
Desprendimiento prematuro de placenta normalmente inserta (DPPNI) como modelo clínico experimental Alteraciones de la hemostasia en Obstetricia..
Clínica Ginecológica., pp. 123-143
[31.]
N Aoki, H Saito, T Kamiya, K Koie, Y Sakata, Y. Kobakira.
Congenital deficiency of alfa2-plasmina inhibitor associated with severe hemorrhagic tendency.
J Clin Invest, 63 (1979), pp. 877-884
[32.]
J Aznar, A Estellés, V Vila, E Regañon, F España, P. Villa.
Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
Tromb Haemost, 52 (1984), pp. 196-200
[33.]
C. Raby.
Síndromes clínicos en los que puede evocarse una coagulación intravascular diseminada.
Coagulaciones intravasculares diseminadas y localizadas, pp. 71-124
[34.]
RL. Bick.
Clinical hemostasis practice: the major impact of laboratory automation.
Sem Thrombos Haemost, 9 (1983), pp. 139-171
[35.]
HC. Kwaan.
The role of fibrinolysis in disease proceses.
Sem Thrombos Haemost, 10 (1984), pp. 71-79
[36.]
B Bennet, D. Ogston.
Fibrinolytic bleeding syndromes.
Disorders of hemostasis, pp. 321-349
[37.]
JJ Parrilla, J Aznar, A Estellés, E Díez, J. Gilabert.
La actividad fibrinolítica del extracto salino de endometrio humano.
Sangre, 20 (1975), pp. 306-310
[38.]
B Alstedt, F. Nordenskjold.
Plasminogen activators in endometriosis.
Acta Obstet Gynecol Scand, 123 (1984), pp. 23-24
[39.]
NA Marsh, PJ. Gaffney.
On the origin of plasma plasminogen activator in man [resumen].
Thromb Haemost, 362 (1979), pp. 421-422
[40.]
B. Astedt.
Fibrinolytic activity during labor.
Acta Obstet Gynecol Scand, 51 (1972), pp. 171-172
[41.]
J. Bonnar.
Blood coagulation and fibrinolysis in human pregnancy.
Biol Anat, 12 (1973), pp. 58-63
[42.]
D. Collen.
Fibrinolysis: mechanism and clinical aspects.
Hemostasis and thrombosis, pp. 237-258
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
